The i3+3 design is accepted and presented at a poster at 2019 ASCO Annual Meeting

Laiya founder Yuan Ji, Professor of Biostatistics at The University of Chicago, presented a poster entitled “The i3+3 Design for Phase I Clinical Trials” at 2019 ASCO Annual Meeting in Chicago, USA.

The i3+3 design is the first rule-based dose-finding design with a performance in par with model-based designs like mTPI and mTPI-2. The paper by Meizi Liu (U Chicago), Sue-Jane Wang (US FDA), and Yuan Ji (U Chicago) has been accepted for publication in the Journal of Biopharmaceutical Statistics.

The i3+3 design has been implemented for multiple clinical trials in China and US already. We have also implemented the design in our U-Design SaaS platform available at https://udesign.laiyaconsulting.com . Check it out!

Leave a Reply

Your email address will not be published. Required fields are marked *